Xtant Medical Holdings, Inc. Announces Expiration of Rights Offering
June 19, 2018 08:00 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, MT, June 19, 2018 (GLOBE NEWSWIRE) -- XtantTM Medical Holdings, Inc. (NYSE American: XTNT) announces that the subscription period for its previously announced rights offering (the...
Xtant Medical Announces Compliance with NYSE American
February 15, 2018 16:45 ET
|
Xtant Medical Holdings, Inc.
Reports Pro Forma Stockholders’ Equity of approximately $47.4M as of 2/15/18Xtant has regained compliance with the NYSE American listing standards BELGRADE, Mont., Feb. 15, 2018 (GLOBE NEWSWIRE) --...
Xtant Medical Announces Exchange of Outstanding Convertible Notes and Closing of Private Placement
February 14, 2018 16:30 ET
|
Xtant Medical Holdings, Inc.
Exchange of $70.238M (plus interest) of convertible notes into 10,401,309 shares of common stock at $7.20 per share.$6.809M Private Placement representing 945,819 shares of common stock at $7.20 per...
Xtant Medical Announces Results of Special Meeting of Stockholders
February 13, 2018 14:55 ET
|
Xtant Medical Holdings, Inc.
Approval of the issuance of new shares of common stock, as required by the NYSE American.Approval of an amendment to its certificate of incorporation, enabling its previously announced 1:12 reverse...
Xtant Medical Enters into Restructuring and Exchange Agreement with All Holders of Outstanding Convertible Notes
January 18, 2018 08:30 ET
|
Xtant Medical Holdings, Inc.
Conversion of $1.627M (plus interest) of convertible notes into common stockExchange of $70.238M (plus interest) of convertible notes into common stockUpon stockholder approval, amendment of...
Xtant Medical Reports Third Quarter 2017 Financial Results
November 21, 2017 15:39 ET
|
Xtant Medical Holdings, Inc.
Company restructuring efforts continue to gain traction towards profitability Third Quarter 2017 Highlights Reported third quarter 2017 revenue of $19.8 million compared to $23.1 million reported...
Xtant Medical Postpones Release of Third Quarter 2017 Financial Results
November 09, 2017 07:30 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of regenerative medicine products and medical devices, announced...
Xtant Medical Enters into a Distribution Agreement with curasan, Inc. Bringing Matriform™ to Market
November 01, 2017 16:30 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of regenerative medicine products and medical devices, today...
Xtant Medical to Announce Third Quarter 2017 Results on Wednesday, November 8th
October 27, 2017 12:04 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Oct. 27, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of regenerative medicine products and medical devices, today...
Xtant Medical to Feature Product Portfolio at the 2017 North American Spine Society Annual Meeting
October 25, 2017 10:12 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of regenerative medicine products and medical devices, announced it...